A second AML study analysed 215 newly diagnosed leukaemic patients and CD34+ cells from four healthy subjects using a multiplexing real-time quantitative polymerase chain reaction (qRT-PCR) method (Jongen-Lavrencic et al, 2008). The gene discussed is CD34; the disease is acute myeloid leukemia.